AI Verdict
ODYS has stronger fundamentals based on our AI analysis.
ODYS vs OCUL Fundamental Comparison
| Metric | ODYS | OCUL |
|---|---|---|
| Revenue | $3.0M | $52.0M |
| Net Income | $-17.0M | $-265.9M |
| Net Margin | -565.0% | -511.9% |
| ROE | -67.0% | -40.6% |
| ROA | -58.8% | -32.9% |
| Current Ratio | 9.17x | 15.39x |
| Debt/Equity | 0.00x | 0.04x |
| EPS | $-1.07 | $-1.42 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ODYS vs OCUL: Frequently Asked Questions
Is ODYS or OCUL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ODYS has stronger fundamentals. ODYS is rated SELL (79% confidence) while OCUL is rated SELL (72% confidence). This is not investment advice.
How does ODYS compare to OCUL fundamentally?
Odysight.ai Inc. has ROE of -67.0% vs OCULAR THERAPEUTIX, INC's -40.6%. Net margins are -565.0% vs -511.9% respectively.
Which stock pays higher dividends, ODYS or OCUL?
ODYS has a dividend yield of N/A or no dividend while OCUL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ODYS or OCUL for long term?
For long-term investing, consider that ODYS has SELL rating with 79% confidence, while OCUL has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ODYS vs OCUL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ODYS vs OCUL, the AI consensus favors ODYS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.